“Prepare for AI Meltdown”
November 5, 2026 Bonus Content: Cigna Just Beat Estimates. Now It Has to Prove CVS Was the Exception. A note…
November 5, 2026 Bonus Content: Cigna Just Beat Estimates. Now It Has to Prove CVS Was the Exception. A note…
Record Q3 margins and a Q4 guidance beat make APP compelling, but a Delaware-to-Nevada reincorporation adds a governance wrinkle worth pricing in.
Hinojosa’s win lands on top of an ERCOT interconnection freeze already running, and December 10 is the date every investment committee should have circled.
November 4, 2026 With Democrats confirmed to control the Senate, the debate is what part of COIN and CRCL ever…
November 4, 2026 Bonus Content: Healthcare Stocks Are Up About 20%. The ACA Vote Is in the Price. A note…
November 4, 2026 Bonus Content: Boeing’s Wing Problem Is Bigger Than the Headline Miss A note from our friends at…
A one-month-low dollar and a 2.4% Nasdaq-100 futures swing diverge. Only one should drive your positioning.
The October model overhaul looks clean on paper. The SMB churn signal buried in Q2 data tells a harder story ahead of tomorrow’s earnings.
The question institutional investors have been circling all year crystallized on Monday in a single filing. Oracle priced a roughly…
A note from our friends at The Agora Companies(ad) Exposed: The Millionaire Lifestyle You Could Have (Without Millions) A luxury…